The clear cell renal carcinoma is the most common malignant neoplasm in the kidney. We present the clinical case of a 58-year-old patient with a history of weight loss of 10 kg in six months and fatigue. Her medical history highlights a left total nephrectomy due to a benign tumor. Currently, she is admitted to our service for a right partial nephrectomy due to suspicion of clear cell renal carcinoma. We consider this case report relevant due to the bilateral presentation of a tumor, both of which underwent nephrectomy.

Keywords: Clear Cell Renal Carcinoma; Partial Nephrectomy; Endothelial Growth Factor; Radiotherapy and Case Report

References

1. Siegel Rebecca L., et al. “Cancer statistics, 2023”. CA: A Cancer Journal for Clinicians1 (2023): 17-48.
2. Blanc Julien and Beat Roth. “Clear cell renal cancer metastasis in the contralateral ureter: a case report”. Journal of Medical Case Reports1 (2021): 309.
3. Uscanga Yépez Jaime., et al. “Diferencias en los indicadores pronóstico de supervivencia en pacientes con cáncer de células renales entre el medio hospitalario público y privado”. Revista Mexicana de Urología 77 2 (2017).
4. Bahadoram, Sara., et al. “Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment”. Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia3 (2022).
5. Ikuerowo, S O., et al. “Paraneoplastic syndromes and oncological outcomes in renal cancer”. Nigerian Journal of Clinical Practice9 (2019): 1271-1275.
6. Hori Shunta., et al. “Impact of Radical Nephrectomy and Partial Nephrectomy on Actual Estimated Overall Survival Compared to Life Expectancy in Patients with Renal Cell Carcinoma”. Research and Reports in Urology 13 (2021): 155-165.
7. Jonasch, Eric., et al. “Clear cell renal cell carcinoma ontogeny and mechanisms of lethality”. Nature Reviews. Nephrology4 (2021): 245-261.
8. Wolf, Melissa M., et al. “Modeling clear cell renal cell carcinoma and therapeutic implications”. Oncogene17 (2020): 3413-3426.
9. Padala Sandeep Anand., et al. “Epidemiology of Renal Cell Carcinoma”. World Journal of Oncology 11,3 (2020): 79-87.
10. Dudani Shaan., et al. “Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival”. JAMA Network Open1 (2021): e2021869.
11. Stolpa Weronika., et al. “Clear Cell Renal Cell Carcinoma, Diagnostic and Therapeutic Difficulties, Case Report and Literature Review”. Medicina (Kaunas, Lithuania)10 (2022): 1329.
12. Gray Richard E and Gabriel T Harris. “Renal Cell Carcinoma: Diagnosis and Management”. American family physician3 (2019): 179-184.
13. Makhov Peter., et al. “Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies”. Molecular Cancer Therapeutics7 (2018): 1355-1364.
14. Deleuze Antoine., et al. “Immunotherapy in Renal Cell Carcinoma: The Future Is Now”. International Journal of Molecular Sciences7 (2020): 2532.
15. Grammatikaki, Stamatiki., et al. “An Overview of Epigenetics in Clear Cell Renal Cell Carcinoma”. In vivo (Athens, Greece)1 (2023): 1-10.
16. Méjean, Arnaud., et al. “Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma”. The New England Journal of Medicine5 (2018): 417-427.
17. Mingote Pablo A., et al. “Expresión de Hemo Oxigenasa-1 y agresividad del carcinoma renal de células claras” [Expression of Hemeoxygenase-1 and clear cell renal cell carcinoma aggressiveness.]”. Archivos espanoles de urologia9 (2020): 794-802.

Citation

Citation: Jesús Arturo Herrera Martínez., et al. “Clear Cell Renal Carcinoma in a 58-year-old Single-Kidney Patient: A Case Report”.Acta Scientific Cancer Biology 8.4 (2024): 34-38.

Copyright

Copyright: © 2024 Jesús Arturo Herrera Martínez., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.